AlphaYou
Overview
Key stats
Fundamentals Sep 10- Open
- $82.70
- 52-wk high
- $91.53
- High
- $91.53
- 52-wk low
- $48.20
- Low
- $81.07
- Prev close
- $83.21
- Mkt cap
- $3.83B
- Volume
- 1.60M
- Fwd P/E
- 83.3x
- Beta
- 0.54
- P/S
- 6.3x
- P/B
- 11.5x
- Profit margin
- -7.7%
- Op margin
- -11.5%
- ROE
- -13.7%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
Earnings
Earnings came in 104.8% below what analysts expected.
Earnings per share
-$0.21 expected
Reports Nov 3, 2026, in 54 days
EPS expected
-$1.96 to -$1.71
Revenue expected
3 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $118.7M | $151.7M | $162.1M | $173.9M |
| Cost of what it sold | $24.6M | $10.9M | $9.4M | $12.1M |
| Gross profit | $94.1M | $140.7M | $152.7M | $161.8M |
| What it spent | ||||
| Research and development | $16.3M | $18.0M | $22.4M | $31.0M |
| Sales and admin | $108.6M | $130.7M | $136.4M | $150.7M |
| Other operating costs | -$16.3M | — | — | — |
| Total operating expenses | $108.6M | $148.7M | $158.8M | $181.7M |
| What was left | ||||
| Operating profit | -$14.5M | -$8.0M | -$6.1M | -$19.9M |
| Interest on debt | $2.1M | $2.2M | $2.1M | $2.2M |
| Profit before tax | -$12.6M | -$6.3M | -$9.3M | -$15.8M |
| Tax | — | $2.1M | -$2.4M | $2.7M |
| Net profit | -$12.6M | -$8.4M | -$7.0M | -$18.6M |
| EBITDA | -$12.1M | -$3.7M | -$6.8M | -$12.7M |
Technicals
Price structure
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bullish
Tone of tracked coverage
Tarsus Pharmaceuticals Acquires Alkeus, Gildeuretinol for Stargardt Disease
BullishSep 5Tarsus Pharmaceuticals stock hits all-time high at 85.29 USD By Investing.com
BullishSep 4Tarsus Pharmaceuticals stock hits all-time high at 85.29 USD By Investing.com
BullishSep 4Tarsus Pharmaceuticals Shares Rise After Closing Alkeus Pharmaceuticals Acquisition
BullishSep 4Tarsus to Participate in Upcoming Investor Conferences
NeutralSep 1After $3.8M sale, Tarsus (TARS) ex-officer plans more selling
NeutralAug 25
Macro
10 macro signals shaping TARS right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results